☰

Kevin Baranger, Ph.D - Publications

Affiliations: 
Université de la Méditerranée, Marseille, Provence-Alpes-Côte d'Azur, France 
Tree Info Grants Similar researchers PubMed Report error

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Migliorati M, Manrique C, Rahrah M, Escoffier G, El Ahmadi A, Girard SD, Khrestchatisky M, Rivera S, Baranger K, Roman FS. The Helico Maze Detects Early Impairment of Reference Memory at Three Months of Age in the 5XFAD Mouse Model of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 36093693 DOI: 10.3233/JAD-220281  0.359
2022 Pilat D, Paumier JM, García-González L, Louis L, Stephan D, Manrique C, Khrestchatisky M, Di Pasquale E, Baranger K, Rivera S. MT5-MMP promotes neuroinflammation, neuronal excitability and Aβ production in primary neuron/astrocyte cultures from the 5xFAD mouse model of Alzheimer's disease. Journal of Neuroinflammation. 19: 65. PMID 35277173 DOI: 10.1186/s12974-022-02407-z  0.478
2021 García-González L, Paumier JM, Louis L, Pilat D, Bernard A, Stephan D, Jullien N, Checler F, Nivet E, Khrestchatisky M, Baranger K, Rivera S. MT5-MMP controls APP and β-CTF/C99 metabolism through proteolytic-dependent and -independent mechanisms relevant for Alzheimer's disease. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 35: e21727. PMID 34117802 DOI: 10.1096/fj.202100593R  0.411
2020 Zipfel P, Rochais C, Baranger K, Rivera S, Dallemagne P. Matrix Metalloproteinases as New Targets in Alzheimer's Disease: Opportunities and Challenges. Journal of Medicinal Chemistry. PMID 32459966 DOI: 10.1021/Acs.Jmedchem.0C00352  0.508
2019 Rochais C, Lecoutey C, Hamidouche K, Giannoni P, Gaven F, Cem E, Mignani S, Baranger K, Freret T, Bockaert J, Rivera S, Boulouard M, Dallemagne P, Claeysen S. Donecopride, a Swiss army knife with potential interest against Alzheimer's disease. British Journal of Pharmacology. PMID 31881553 DOI: 10.1111/Bph.14964  0.448
2019 García-González L, Pilat D, Baranger K, Rivera S. Emerging Alternative Proteinases in APP Metabolism and Alzheimer's Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP. Frontiers in Aging Neuroscience. 11: 244. PMID 31607898 DOI: 10.3389/Fnagi.2019.00244  0.556
2019 Baranger K, van Gijsel-Bonnello M, Stephan D, Carpentier W, Rivera S, Khrestchatisky M, Gharib B, De Reggi M, Benech P. Long-Term Pantethine Treatment Counteracts Pathologic Gene Dysregulation and Decreases Alzheimer's Disease Pathogenesis in a Transgenic Mouse Model. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 31267473 DOI: 10.1007/S13311-019-00754-Z  0.457
2019 Rivera S, García-González L, Khrestchatisky M, Baranger K. Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders. Cellular and Molecular Life Sciences : Cmls. PMID 31197405 DOI: 10.1007/S00018-019-03178-2  0.49
2018 Paumier JM, Py NA, García-González L, Bernard A, Stephan D, Louis L, Checler F, Khrestchatisky M, Baranger K, Rivera S. Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP-2 and BACE-1 activities, and the modulation of APP trafficking. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201801076R. PMID 30332299 DOI: 10.1096/Fj.201801076R  0.539
2018 Morello M, Landel V, Lacassagne E, Baranger K, Annweiler C, Féron F, Millet P. Vitamin D Improves Neurogenesis and Cognition in a Mouse Model of Alzheimer's Disease. Molecular Neurobiology. PMID 29318446 DOI: 10.1007/S12035-017-0839-1  0.341
2017 Baranger K, Giannoni P, Girard SD, Girot S, Gaven F, Stephan D, Migliorati M, Khrestchatisky M, Bockaert J, Marchetti-Gauthier E, Rivera S, Claeysen S, Roman FS. Chronic treatments with a 5-HT4 receptor agonist decrease amyloid pathology in the entorhinal cortex and learning and memory deficits in the 5xFAD mouse model of Alzheimer's disease. Neuropharmacology. PMID 28844596 DOI: 10.1016/J.Neuropharm.2017.08.031  0.488
2017 van Gijsel-Bonnello M, Baranger K, Benech P, Rivera S, Khrestchatisky M, de Reggi M, Gharib B. Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer's disease: Alleviation by pantethine. Plos One. 12: e0175369. PMID 28410378 DOI: 10.1371/Journal.Pone.0175369  0.305
2016 Baranger K, Bonnet AE, Girard SD, Paumier JM, García-González L, Elmanaa W, Bernard A, Charrat E, Stephan D, Bauer C, Moschke K, Lichtenthaler SF, Roman FS, Checler F, Khrestchatisky M, et al. MT5-MMP Promotes Alzheimer's Pathogenesis in the Frontal Cortex of 5xFAD Mice and APP Trafficking in vitro. Frontiers in Molecular Neuroscience. 9: 163. PMID 28119565 DOI: 10.3389/Fnmol.2016.00163  0.571
2016 Baranger K, Khrestchatisky M, Rivera S. MT5-MMP, just a new APP processing proteinase in Alzheimer's disease? Journal of Neuroinflammation. 13: 167. PMID 27349644 DOI: 10.1186/S12974-016-0633-4  0.562
2016 Landel V, Millet P, Baranger K, Loriod B, Féron F. Vitamin D interacts with Esr1 and Igf1 to regulate molecular pathways relevant to Alzheimer's disease. Molecular Neurodegeneration. 11: 22. PMID 26932723 DOI: 10.1186/S13024-016-0087-2  0.399
2015 Baranger K, Marchalant Y, Bonnet AE, Crouzin N, Carrete A, Paumier JM, Py NA, Bernard A, Bauer C, Charrat E, Moschke K, Seiki M, Vignes M, Lichtenthaler SF, Checler F, et al. MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer's disease. Cellular and Molecular Life Sciences : Cmls. PMID 26202697 DOI: 10.1007/S00018-015-1992-1  0.723
2015 Baranger K, Marchalant Y, Bonnet AE, Crouzin N, Carrete A, Paumier JM, Py NA, Bernard A, Bauer C, Charrat E, Moschke K, Seiki M, Vignes M, Lichtenthaler SF, Checler F, et al. MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer’s disease Cellular and Molecular Life Sciences. DOI: 10.1007/s00018-015-1992-1  0.709
2014 Baranger K, Rivera S, Liechti FD, Grandgirard D, Bigas J, Seco J, Tarrago T, Leib SL, Khrestchatisky M. Endogenous and synthetic MMP inhibitors in CNS physiopathology. Progress in Brain Research. 214: 313-51. PMID 25410364 DOI: 10.1016/B978-0-444-63486-3.00014-1  0.461
2014 Py NA, Bonnet AE, Bernard A, Marchalant Y, Charrat E, Checler F, Khrestchatisky M, Baranger K, Rivera S. Differential spatio-temporal regulation of MMPs in the 5xFAD mouse model of Alzheimer's disease: evidence for a pro-amyloidogenic role of MT1-MMP. Frontiers in Aging Neuroscience. 6: 247. PMID 25278878 DOI: 10.3389/Fnagi.2014.00247  0.702
2014 Landel V, Baranger K, Virard I, Loriod B, Khrestchatisky M, Rivera S, Benech P, Féron F. Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer's disease. Molecular Neurodegeneration. 9: 33. PMID 25213090 DOI: 10.1186/1750-1326-9-33  0.365
2014 Girard SD, Jacquet M, Baranger K, Migliorati M, Escoffier G, Bernard A, Khrestchatisky M, Féron F, Rivera S, Roman FS, Marchetti E. Onset of hippocampus-dependent memory impairments in 5XFAD transgenic mouse model of Alzheimer's disease. Hippocampus. 24: 762-72. PMID 24596271 DOI: 10.1002/Hipo.22267  0.441
2014 Gaven F, Lecoutey C, Giannoni P, Baranger K, Freret T, Ballandonne C, Bouet V, Rivera S, Boulouard M, Rochais C, Dallemagne P, Claeysen S. P4-206: A NOVEL MTDL APPROACH TO ALZHEIMER DISEASE: 5-HT4 RECEPTOR AGONISTS WITH ACETYLCHOLINESTERASE INHIBITORY ACTIVITIES Alzheimer's & Dementia. 10: P863-P864. DOI: 10.1016/J.Jalz.2014.05.1724  0.327
2014 Giannoni P, Baranger K, Girot S, Girard S, Gaven F, Jacquet M, Migliorati M, Rivera S, Claeysen S, Roman F. O2-04-03: MEMORY DEFICITS OF 5XFAD MICE IN THE OLFACTORY H-MAZE TEST CORRELATE WITH PLAQUES DEVELOPMENT AND ARE PREVENTED BY 5-HT4R AGONIST TREATMENTS Alzheimer's & Dementia. 10: P170-P171. DOI: 10.1016/J.Jalz.2014.04.175  0.306
2013 Giannoni P, Gaven F, de Bundel D, Baranger K, Marchetti-Gauthier E, Roman FS, Valjent E, Marin P, Bockaert J, Rivera S, Claeysen S. Early administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer's disease. Frontiers in Aging Neuroscience. 5: 96. PMID 24399967 DOI: 10.3389/Fnagi.2013.00096  0.429
2013 Crouzin N, Baranger K, Cavalier M, Marchalant Y, Cohen-Solal C, Roman FS, Khrestchatisky M, Rivera S, Féron F, Vignes M. Area-specific alterations of synaptic plasticity in the 5XFAD mouse model of Alzheimer's disease: dissociation between somatosensory cortex and hippocampus. Plos One. 8: e74667. PMID 24069328 DOI: 10.1371/Journal.Pone.0074667  0.669
2013 Ould-Yahoui A, Sbai O, Baranger K, Bernard A, Gueye Y, Charrat E, Clément B, Gigmes D, Dive V, Girard SD, Féron F, Khrestchatisky M, Rivera S. Role of matrix metalloproteinases in migration and neurotrophic properties of nasal olfactory stem and ensheathing cells. Cell Transplantation. 22: 993-1010. PMID 23043957 DOI: 10.3727/096368912X657468  0.436
2013 Girard SD, Baranger K, Gauthier C, Jacquet M, Bernard A, Escoffier G, Marchetti E, Khrestchatisky M, Rivera S, Roman FS. Evidence for early cognitive impairment related to frontal cortex in the 5XFAD mouse model of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 33: 781-96. PMID 23042214 DOI: 10.3233/Jad-2012-120982  0.468
2012 Marchalant Y, Baranger K, Wenk GL, Khrestchatisky M, Rivera S. Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention? Journal of Neuroinflammation. 9: 10. PMID 22248015 DOI: 10.1186/1742-2094-9-10  0.686
2012 Bardou I, DiPatrizio N, Brothers HM, Kaercher RM, Baranger K, Mitchem M, Hopp SC, Wenk GL, Marchalant Y. Pharmacological manipulation of cannabinoid neurotransmission reduces neuroinflammation associated with normal aging Health. 4: 679-684. DOI: 10.4236/Health.2012.429107  0.641
2011 Gouget T, Djelloul M, Boucraut J, Weinhard L, Baranger K, Rivera S, Khrestchatisky M, Perrone L. TXNIP, the major player in insulin resistance, is early over-expressed in the brain of the 5XFAD Alzheimer's mice model and is induced by Aβ in vitro: Emerging role of TXNIP and inflammation in Alzheimer's Disease progression Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1973  0.435
Show low-probability matches.